These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12819334)

  • 1. Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation.
    Hagiwara A; Inoue Y; Wakasa K; Haba T; Tashiro T; Miyamoto T
    Radiology; 2003 Aug; 228(2):533-8. PubMed ID: 12819334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas.
    Zada G; Lin N; Laws ER
    Neurosurg Focus; 2010 Oct; 29(4):E4. PubMed ID: 20887129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
    Nishioka H; Haraoka J; Akada K
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):768-72. PubMed ID: 14974920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
    Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
    Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas.
    Mahmoud OM; Tominaga A; Amatya VJ; Ohtaki M; Sugiyama K; Sakoguchi T; Kinoshita Y; Takeshima Y; Abe N; Akiyama Y; El-Ghoriany AI; Abd Alla AK; El-Sharkawy MA; Arita K; Kurisu K; Yamasaki F
    Eur J Radiol; 2011 Nov; 80(2):412-7. PubMed ID: 20580505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation.
    Sarlis NJ; Gourgiotis L; Koch CA; Skarulis MC; Brucker-Davis F; Doppman JL; Oldfield EH; Patronas NJ
    AJR Am J Roentgenol; 2003 Aug; 181(2):577-82. PubMed ID: 12876051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-producing pituitary adenomas: MR characteristics and pre- and postoperative evaluation.
    Chakrabortty S; Oi S; Yamaguchi M; Tamaki N; Matsumoto S
    Neurol Med Chir (Tokyo); 1993 Feb; 33(2):81-5. PubMed ID: 7682670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic location and growth patterns of functioning pituitary adenomas: correlation with histological distribution of hormone-secreting cells in the pituitary gland.
    Baik JS; Lee MH; Ahn KJ; Choi HS; Jung SL; Kim BS; Jeun SS; Hong YK
    Clin Imaging; 2015; 39(5):770-4. PubMed ID: 26115915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human pituitary growth hormone cell adenomas, ultrastructural and immunoelectron microscopical study].
    Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):102-4. PubMed ID: 2582544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.
    Lu JQ; Adam B; Jack AS; Lam A; Broad RW; Chik CL
    Endocr Pathol; 2015 Sep; 26(3):263-72. PubMed ID: 26187094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
    Yamada S; Aiba T; Sano T; Kovacs K; Shishiba Y; Sawano S; Takada K
    Neurosurgery; 1993 Jul; 33(1):20-7. PubMed ID: 7689191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of normal perisellar anatomy in 1.5 T T2-weighted MRI and comparison with the anatomic criteria defining cavernous sinus invasion of pituitary adenomas.
    Knappe UJ; Jaursch-Hancke C; Schönmayr R; Lörcher U
    Cent Eur Neurosurg; 2009 Aug; 70(3):130-6. PubMed ID: 19701871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
    Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of pituitary adenomas with sphenoid sinus invasion: characteristic MR findings indicating fibrosis.
    Ishii K; Ikeda H; Takahashi S; Matsumoto K; Ishibashi T; Tazawa S
    Radiat Med; 1996; 14(4):173-8. PubMed ID: 8916258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
    Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
    Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of pituitary adenomas on touch preparations assisted by immunocytochemistry.
    Kontogeorgos G; Bassiouka I; Giannou P; Vamvassakis E; Rologis D; Orphanidis G
    Acta Cytol; 1995; 39(2):141-52. PubMed ID: 7887060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance imaging (MRI) of pituitary adenomas].
    Nemoto Y; Inoue Y; Fukuda T; Takemoto K; Matumura Y; Syakudo M; Onoyama Y; Hakuba A; Nishimura S
    No To Shinkei; 1987 Nov; 39(11):1049-54. PubMed ID: 3442635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CT findings of growth hormone secreting pituitary adenomas].
    Yamagami T; Hashimoto N; Kojima M; Ishikawa M; Handa H
    No To Shinkei; 1986 Mar; 38(3):239-46. PubMed ID: 3011040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of cavernous sinus involvement by pituitary adenomas.
    Scotti G; Yu CY; Dillon WP; Norman D; Colombo N; Newton TH; De Groot J; Wilson CB
    AJR Am J Roentgenol; 1988 Oct; 151(4):799-806. PubMed ID: 3262283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
    Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
    Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.